Cytori Therapeutics, Inc. Names John Ransom, Ph.D., Vice President Of Research, Regenerative Cell Technology
SAN DIEGO--(BUSINESS WIRE)--Dec. 14, 2005--Cytori Therapeutics, Inc. (Frankfurt: XMPA) announced today the appointment of John Ransom, Ph.D., to Vice President of Research, Regenerative Cell Technology. Dr. Ransom will direct the Company's adipose stem and regenerative cell therapy discovery efforts.